Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Providers

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The aviation and finance industries' past experiences accessing federal programs mirror providers' current experiences.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Four tactical considerations to ensure your pandemic reaction is expedited, purposeful, and meaningful.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

A closer look at how new healthcare reform is helping providers navigate COVID-19's uncertainty.

Partner, Nixon Peabody
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

How New Price Transparency Rules May Impact Payers and Providers

Immediate considerations for the industry.

Principal, Health and Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe
Engage Consumers September 05, 2019

Let the Data Flow

We're at the tipping point of consumer data transformation. We just have to want to share this data, not hold onto it for ourselves.

VP of Products, HeathSparq

A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.

Partner, Health and Life Sciences, Oliver Wyman
Senior Knowledge Expert, Health & Life Sciences, Oliver Wyman

The healthcare industry struggles with keeping insurance costs low and quality high. One solution? Walgreens’ new incentive-based care model.

Perceptions of behavioral health are evolving. Here’s why a multi-faceted approach to behavioral health brings more value to patients.

Principal, Health and Life Sciences, Oliver Wyman
Chief Medical Officer, AbleTo

Oliver Wyman's analysis of small group market risk adjustment examines past formulas, models, and systems to predict the future.

Practice Leader, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe